You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Forest Laboratories Inc. v. Apotex Corp. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Forest Laboratories Inc. v. Apotex Corp. (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-02-14
Court	District Court, D. Delaware	Date Terminated	2016-02-16
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	8,168,209; 8,173,708; 8,283,379; 8,329,752; 8,362,085; 8,598,233
Link to Docket	External link to docket

Small Molecule Drugs cited in Forest Laboratories Inc. v. Apotex Corp.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Forest Laboratories Inc. v. Apotex Corp. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2014-02-13	1		quot;the '708 patent"); 8,283,379 ("the '379 patent"); 8,329,752 ("the '…#39;009 patent, the '209 patent, the '708 patent, the '379 patent, the '752 patent, the … '009 patent, the '209 patent, the '708 patent, the ‘379 patent, the ‘752 patent, and the …#39;009 patent, the '209 patent. the '708 patent, the ‘3 79 patent, the '752 patent, the '…#39;009 patent, the '209 patent, the '708 patent, the '379 patent, the '752 patent, the	External link to document
2016-02-10	217		infringement of U.S. Patent Nos. 8,039,009 (“the ‘009 Patent”); 8,168,209 (“the ‘209 Patent”); 8,173,708 (“…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, and…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, and…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, the…‘009 Patent, the ‘209 Patent, the ‘708 Patent, the ‘379 Patent, the ‘752 Patent, the ‘085 Patent, and	External link to document
2014-02-13	3		Expiration of Patent: 8,039,009-03/24/2029; 8,168,209, 8,173,708, 8,283,379, 8,329,752, 8,362,085, 8,… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 16 February 2016 1:14-cv-00200 830 Patent None District Court, D. Delaware	External link to document
2014-02-14	4		Expiration of Patent: 8,039,009-03/24/2029; 8,168,209, 8,173,708, 8,283,379, 8,329,752, 8,362,085, 8,… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 16 February 2016 1:14-cv-00200 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.